By Deena Beasley LOS ANGELES (Reuters) – Amgen Inc’s experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company…
Go toTop
By Deena Beasley LOS ANGELES (Reuters) – Amgen Inc’s experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company…